Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150210 · ClinicalTrials.gov registry record · NA
SP Thoracic IDE Study
A NA study of Myasthenia Gravis and Thymoma, sponsored by Intuitive Surgical.
- Active
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 6
- Study locations
NCT05150210: Active NA study of Myasthenia Gravis and Thymoma, sponsored by Intuitive Surgical.
NCT05150210 is a NA study of Myasthenia Gravis and Thymoma that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 32 participants, below the 190-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05150210, a NA study of Myasthenia Gravis and Thymoma, is active but no longer recruiting, sponsored by Intuitive Surgical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 6
- Study locations
Study Summary
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in pulmonary lobectomy, and in thymectomy procedures.
Primary Outcome
Performance defined as the ability to complete the planned da Vinci SP-assisted pulmonary lobectomy and thymectomy procedures without conversion to an alternate approach
Conditions Studied
Interventions
- DEVICE Robotic-Assisted Surgery
Study Locations (6)
New York
- NYU Langone Health - New York
- Memorial Sloan Kettering Cancer Center - New York
California
- Cedars-Sinai Medical Center - Los Angeles
Massachusetts
- Brigham and Women's Hospital - Boston
North Carolina
- Duke University Hospital - Durham
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2028-07 |
| Phase | NA |
What the registry record for NCT05150210 still lists
NCT05150210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 190-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (83% lower).
The record links to 4 conditions, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which Robotic-Assisted Surgery is the first listed.
NCT05150210 lists 6 locations in 5 states (New York, California, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05150210 about?
NCT05150210 is a clinical study titled "SP Thoracic IDE Study". To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in pulmonary lobectomy, and in thymectomy procedures.
What is the current status of trial NCT05150210?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-07-20. Estimated completion is 2028-07.
What conditions does trial NCT05150210 study?
This clinical trial studies the following conditions: Myasthenia Gravis, Thymoma, Primary Lung Cancer, Benign Lung Disease.
What interventions are being tested in trial NCT05150210?
The interventions under investigation include: Robotic-Assisted Surgery (DEVICE).
Who is sponsoring clinical trial NCT05150210?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150210 being conducted?
This trial has 6 study locations across California, Massachusetts, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05150210's enrollment target sits among peer trials
32 25th of 32 higher than 8 of 32 other Myasthenia Gravis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myasthenia Gravis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
-
Clinical Trial to Improve the Magnetic Levator Prosthesis
COMPLETED · NA
-
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
COMPLETED · NA
-
Acupuncture in Myasthenia Gravis (AcuMG)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI